EXEMESTANE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70301-2017
  • Package NDC 70301-2017-1
  • Application number ANDA200898
  • SPL ID 5e37d1b3-080b-4c7d-e063-6294a90af995
  • SPL set ID 392b5b4f-3fb4-4ba7-a15a-6022298db719
  • UNII NY22HMQ4BX
  • RxCUI 310261

What the source publishes

Labeler
OPKO Pharmaceuticals, LLC
Active ingredients
EXEMESTANE
Form
TABLET, COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70301-2017_5e37d1b3-080b-4c7d-e063-6294a90af995
{
  "name": "EXEMESTANE",
  "splId": "5e37d1b3-080b-4c7d-e063-6294a90af995",
  "labels": [
    {
      "setId": "392b5b4f-3fb4-4ba7-a15a-6022298db719",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=392b5b4f-3fb4-4ba7-a15a-6022298db719",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=392b5b4f-3fb4-4ba7-a15a-6022298db719"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "OPKO Pharmaceuticals, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, COATED in 1 BOTTLE (70301-2017-1)",
      "package_ndc": "70301-2017-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20261031"
    }
  ],
  "productId": "70301-2017_5e37d1b3-080b-4c7d-e063-6294a90af995",
  "useDomain": "unknown",
  "dosageForm": "TABLET, COATED",
  "productNdc": "70301-2017",
  "deaSchedule": null,
  "genericName": "EXEMESTANE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EXEMESTANE",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "ANDA200898",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20261031",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175563",
      "N0000175080"
    ],
    "upc": [
      "0370301201711"
    ],
    "unii": [
      "NY22HMQ4BX"
    ],
    "rxcui": [
      "310261"
    ],
    "spl_set_id": [
      "392b5b4f-3fb4-4ba7-a15a-6022298db719"
    ],
    "pharm_class_epc": [
      "Aromatase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Aromatase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "OPKO Pharmaceuticals, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70301-2017_5e37d1b3-080b-4c7d-e063-6294a90af995"